CD274 and neoplasm: Studies have shown that PD-L1 on the surface of tumor-derived exosomes can suppress anti-tumor immunity locally or systemically by binding to programmed death-1 (PD-1) on T cells, facilitating immune escape and promoting tumor progression (8).